Suzhou Zelgen Biopharmaceuticals Co.,ltd
Clinical trials sponsored by Suzhou Zelgen Biopharmaceuticals Co.,ltd, explained in plain language.
-
New hope for rare cancer: ZG006 faces chemo in phase 3 showdown
Disease control Not yet recruitingThis study tests a new drug called ZG006 against standard chemotherapy in 240 adults with advanced neuroendocrine carcinoma, a rare cancer. Participants must have a specific marker (DLL3) and have already tried at least one prior treatment. The main goal is to see if ZG006 helps …
Phase: PHASE3 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Healthy volunteers needed to test two versions of an experimental drug
Knowledge-focused Not yet recruitingThis study looks at how two different versions of gecacitinib hydrochloride tablets are absorbed and processed by the body in healthy adults. About 64 participants aged 18 to 45 will take a single dose under fasting conditions. The goal is to compare the drug levels in the blood,…
Phase: PHASE1 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Knowledge-focused
Last updated May 26, 2026 09:03 UTC